Most Americans use social media, making it a crucial tool in oncology, where new findings, biomarkers, treatments, and trials are presented.

To enroll in clinical trials for targeted cancer therapies, people must be aware of them; thus, raising awareness is vital to enrollment.

Cancer clinical trial diversity is poor, which matters because of different treatment responses. Solutions are vital to improve trials.

A CMO is responsible for compound development success, so building awareness proactively and compliantly is critical for clinical trials.

Clinical trials held in the UK have seen patient enrollment and trial numbers drop. Flexibility & creativity are needed to overcome issues.

Patient advocacy groups provide support, education, advocacy, and information sharing while including the patient perspective in healthcare.

Social media is an affordable, accessible, and rapid means by which people with cancer can gain awareness about cancer clinical trials.